Scott J Hecker

This inventor holds 63 USPTO granted patents and 18 published patent applications, plus 7 CIPO patents and 25 EPO patents, primarily in Boronic Acid Derivatives (CPC class A61K). Top assignees: Rempex Pharmaceuticals, Inc., Metabasis Therapeutics, Inc., Qpex Biopharma, Inc.. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott J Hecker. Retrieved from https://idiyas.com/inventor/scott-j-hecker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 63 (Patent Applications = 18)

% Patents Active = 77.8

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 25 (Patent Applications = 26)

Average Co-Inventor Count = 4.9

ph-index = 13

Forward Citations = 556(Granted Patents)

Forward Citations (Not Self Cited) = 184(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Los Gatos, CA (US) (2002 - 2004)
San Diego, CA (US) (2006)
Del Mar, CA (US) (2006 - 2024)

Company Filing History:

20 out of 27

Rempex Pharmaceuticals, Inc.

patents

14 out of 64

Metabasis Therapeutics, Inc.

Melinta Subsidiary Corp.

patents

5. 4 out of 30

Schering-Plough Animal Health Corporation

Essential Therapeutics, Inc.

Trine Pharmaceuticals, Inc.

patents

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Boronic Acid Derivatives

Glucagon Antagonists

Tetracycline Compositions

Cyclic Boronic Acid Esters

Therapeutic Uses

Synthesis Methods

Pharmaceutical Compositions

Bile Acid Sequestrants

Inhibitors of DGAT-1

Polymorphic Forms

Antimicrobials

Boronate Salts

63 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637481 - Boronic acid derivatives and therapeutic uses thereof (2026-05-26),

2. 12552815 - Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof (2026-02-17),

3. 12509475 - Boronic acid derivatives and therapeutic uses thereof (2025-12-30),

4. 12171772 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2024-12-24),

5. 12161656 - Tetracycline compositions (2024-12-10),

6. 12016868 - Boronic acid derivatives and therapeutic uses thereof (2024-06-25),

7. 11999759 - Boronic acid derivatives and therapeutic uses thereof (2024-06-04),

8. 11999757 - Synthesis of boronate ester derivatives and uses thereof (2024-06-04),

9. 11944634 - Tetracycline compositions (2024-04-02),

10. 11684629 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2023-06-27),

11. 11352321 - Glucagon antagonists (2022-06-07),

12. 11286270 - Boronic acid derivatives and synthesis thereof (2022-03-29),

13. 11180512 - Boronic acid derivatives and therapeutic uses thereof (2021-11-23),

14. 11090319 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2021-08-17),

15. 10807946 - Antagonists of the glucagon receptor (2020-10-20),

Title: The Innovative Journey of Scott J Hecker

Introduction: Scott J Hecker, a talented inventor based in Del Mar, CA (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Scott J Hecker's latest patents include cutting-edge solutions in the realm of artificial intelligence, renewable energy, and sustainable materials.

Career Highlights: With a career spanning over two decades, Scott J Hecker has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing pioneering solutions to address them.

Collaborations: Throughout his career, Scott J Hecker has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life and make a lasting impact on society.

Conclusion: Scott J Hecker's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.